Published April 17, 2020 | Version v2
Journal article Open

COVID-19 (CORONAVIRUS): A GLOBAL EMERGENCY OUTBREAK AND ITS IMPLICATIONS IN INDIA

Authors/Creators

  • 1. Professor, Department of Zoology, Karnatak University, Dharwad-580 003, India

Description

Global outbreak of coronavirus disease 2019 (Covid-19) challenged the medical facilities and services worldwide with more than 200 countries affected by the pandemic. SARS-CoV-2, the seventh virus known to infect the human respiratory system, belongs to the genus Betacoronavirus. It affects the respiratory tract mainly by binding to the ACE-2 receptors chiefly found in lungs and heart. Major countries like the United States, Italy, France, and United Kingdom suffered great loss during the Covid-19 pandemic and large numbers of deaths were reported. At the same time, India too is combating against the virus. Covid-19 arrived in India from the global epicenter Wuhan in late January 2020 when a Kerala student tested positive for the virus. Maharashtra was the worst affected state with maximum number of positive cases and deaths in the country. First death due to Covid-19 occurred in Karnataka state that triggered the alarm of Covid-19 infection. Indian government is taking lots of efforts to control the transmission of the virus that spreads rapidly among humans. Strategies such as self-quarantine, social distancing and 40-days countrywide lockdown helped to slow down the virus which could have spread tremendously otherwise. Our review focuses on the implications of Covid-19 in Indian scenario along with report on active cases, death toll, cured cases, and strategies employed for the pandemic control.

Files

5. IJZAB ID No. 506.pdf

Files (490.1 kB)

Name Size
md5:51abd938404dda5ad739ea2cbca61039
490.1 kB Preview Download

Additional details

References

  • Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D.Y., Chen, L., & Wang, M. (2020). Presumed asymptomatic carrier transmission of COVID-19. Jama. doi:10.1001/ jama.2020.2565
  • Benvenuto, D., Giovanetti, M., Ciccozzi, A., Spoto, S., Angeletti, S., & Ciccozzi, M. (2020). The 2019‐new coronavirus epidemic: evidence for virus evolution. Journal of Medical Virology, 92(4), 455-459
  • Bernheim, A., Mei, X., Huang, M., Yang, Y., Fayad, Z. A., Zhang, N., Li, K. (2020). Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology, 200463.
  • Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Wei, M. (2020). A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. New England Journal of Medicine.1-13.
  • Casadevall, A., & Pirofski, L.A. (2020). The convalescent sera option for containing COVID-19. The Journal of Clinical Investigation, 130(4).
  • Chan JFW, Yuan S, Kok KH, Kelvin Kai-Wang to, et al. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person‐to‐person transmission: a study of a family cluster. Lancet, 395, 514‐523.
  • Chinese Society of Radiology. Radiological diagnosis of new coronavirus infected pneumonitis: Expert recommendation from the Chinese Society of Radiology (First edition). (2020). Chin J Radiol, DOI: 10.3760/cma.j.issn.1005-1201.2020.0001
  • Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., Gong, Q. (2020). Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet, 395(10226), 809-815.
  • Chen, L., Xiong, J., Bao, L., & Shi, Y. (2020). Convalescent plasma as a potential therapy for COVID-19
  • Coronavirus disease (COVID-19) Situation Dashboard. 2020. https://who.sprinklr.com.
  • Coronavirus disease 2019 (COVID-19) Situation Report-85: Data as reported by national authorities by 10:00 CET 14 April 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200407-sitrep-78-covid-19.pdf?sfvrsn=bc43e1b_2.
  • Cortegiani, A., Ingoglia, G., Ippolito, M., Giarratano, A., & Einav, S. (2020). A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-
  • Cui J, Li F, Shi ZL. (2019). Origin and evolution of pathogenic coronavirus, Nat Rev Microbiol, 17, 181-92
  • Dhama, K., Sharun, K., Tiwari, R., Sircar, S., Bhat, S., Malik, Y.S. Rodriguez Morales, A.J. (2020). Coronavirus disease 2019–COVID-19. Preprints, 1-61.
  • Dong, L., Hu, S., & Gao, J. (2020). Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discoveries & Therapeutics, 14(1), 58-60.
  • Guidelines on the measures to be taken by ministries/ departments of government of India, State/ union territory governments and state/ union territory authorities for containment of Covid-19 epidemic in the country. (2020). https://mha.gov.in/sites/default/ files/Guidelines.pdf
  • Holshue, M.L., DeBolt, C., Lindquist, S., Lofy, K.H., Wiesman, J., Bruce, H., Tural, A. (2020). First case of 2019 novel coronavirus in the United States. New England Journal of Medicine. 382, 929-936.
  • Kampf, G., Todt, D., Pfaender, S., & Steinmann, E. (2020). Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. Journal of Hospital Infection. 104, 246-251.
  • Kanne, J.P. (2020). Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist: Radiological Society of North America. 295(1), 16-17.
  • Kim, J.Y., Choe, P.G., Oh, Y., Oh, K.J., Kim, J., Park, S.J., (2020). The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. Journal of Korean Medical Science, 35(5).
  • Lam, T. T.Y., Shum, M. H.H., Zhu, H.C., Tong, Y.G., Ni, X.B., Liao, Y.S., Li, L.F. (2020). Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China. BioRxiv.2-3.
  • Lim, J., Jeon, S., Shin, H.Y., Kim, M. J., Seong, Y. M., Lee, W. J., Park, S.J. (2020). Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. Journal of Korean Medical Science, 35(6).
  • Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Zhu, N. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, 395(10224), 565-574.
  • Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., & Richardson, P. (2020). COVID-19: combining antiviral and anti-inflammatory treatments. The Lancet Infectious Diseases.20,400-402.
  • Su, S., Wong, G., Shi, W., Liu, J., Lai, A.C., Zhou, J.,Gao, G. F. (2016). Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology, 24(6), 490-502.
  • Sun Meili, Yang Jianmin, Sun Yuping, et al. (2020). RAS inhibitor is one of the possible options for the treatment of new coronavirus pneumonia (J / OL), Chinese Journal of Tuberculosis and Respiratory Diseases. http: //rs.yiigle.com/yufabiao/1181342.html.
  • Turner, A. J., Hiscox, J.A., & Hooper, N.M. (2004). ACE2: from vasopeptidase to SARS virus receptor. Trends in Pharmacological Sciences, 25(6), 291-294.
  • U.S. and World Population Clock. (2020). https://www. census.gov/popclock
  • Wang M, Cao R, Zhang L, Xinglou Yang, et al. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, 30, 269–271. https://doi.org/10.1038/ s41422-020-0282-0.
  • Wang Q, Wang YH, Ma JC, Jan Han, et al. (2020). Description of the first strain of 2019-nCoV, C-Tan-nCoV Wuhan Strain — National Pathogen Resource Center, China. http://weekly.chinacdc.cn/en/article/id/ e3a460f1-661b-4180-b562-ecd8e9502082
  • WHO. Annex G. Use of disinfectants: alcohol and bleach. Infection prevention and control of epidemic-and pandemic-prone acute respiratory infections in health care. Geneva: WHO. (2014). 65.
  • Yang Y., Yang. M., Shen, C., et al. (2020). Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019‐nCoV infections, https://doi.org/10.1101/2020. 02.11.20 021493.
  • Zhang, L., Shen, F.M., Chen, F., & Lin, Z. (2020). Origin and evolution of the 2019 novel coronavirus. The New England Journl of Medicine,1-13.
  • Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Lu, R. et al. for the China Novel Coronavirus Investigating and Research Team, (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medcine Research and Review, 382(8), 727-733.
  • Zisman, L. S., Rebecca S. Keller, Barbara Weaver, Qishan Lin, et al. (2003). Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart Ventricles: Evidence for Upregulation of the Angiotensin-Converting Enzyme Homologue ACE2. Circulation,108(4), 1707–1712
  • Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Xia, J. (2020). SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England Journal of Medicine, 382(12), 1177-1179.
  • Zu, Z. Y., Jiang, M. D., Xu, P. P., Chen, W., Ni, Q. Q., Lu, G. M., & Zhang, L. J. (2020). Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology, 200-490

Subjects

Zoology
10.5281/zenodo.3755267